Search - tctmd.com

Displaying 681 - 700 of 948

Sort: Relevancy | Date

Presentation TCT 2018

Point Volume Threshold Increases are Needed to Assess Quality and Improve Clinical Outcomes

Presenter: Joseph E. Bavaria

September 22, 2018

Presentation TCT 2018

Opinion Concerns of TAVR Access for Underserved Populations

Presenter: Aaron Horne, Jr.

September 22, 2018

Presentation TCT 2018

Counterpoint Current and Future Demands Will Require TAVR Site Expansion

Presenter: Mark J. Russo

September 22, 2018

Presentation TCT 2018

Point Access Considerations Can be Managed Without Significant TAVR Site Expansion

Presenter: Carl L. Tommaso

September 22, 2018

Presentation TCT 2018

TCT-7: Predictors and Outcomes of Aborted Procedures During Elective Transcatheter Aortic Valve Replacement

Presenter: Steven R. Bailey, Patrick W. Serruys, Jennifer Rymer

September 22, 2018

Presentation TCT 2018

TCT-4: Reduction of Stroke With Use of the Double-Filter Cerebral Embolic Protection Device in Patients Undergoing Transfemoral Aortic Valve Replacement With Self-Expandable, Mechanically Implantable And Balloon-Expandable Aortic Valves

Presenter: Steven R. Bailey, Patrick W. Serruys, Julia Seeger

September 22, 2018

Presentation TCT 2018

TCT-98: Early Clinical Impact of Cerebral Embolic Protection With Transcatheter Aortic Valve Replacement, a Multicenter Study in the Netherlands

Presenter: Alain G. Cribier, Helene Eltchaninoff, Herbert Kroon

September 21, 2018

Presentation TCT 2018

TCT-72: A Prospective Evaluation for Hypoattenuated Leaflet Thickening Following Transcatheter Aortic Valve Replacement

Presenter: Alex Chebl, Alexandra J. Lansky, Liang Tang

September 21, 2018

Presentation TCT 2018

TCT-70: Incidence, Trends, and Risk Factors for Early Stroke after Transcatheter Aortic Valve Replacement in the First 5 years of US Clinical Practice: Report of the STS/ACC TVT Registry.

Presenter: Alex Chebl, Alexandra J. Lansky, Chetan Huded

September 21, 2018

Presentation TCT 2018

Case Conclusion

Presenter: Sarah Clarke, Kim Guibone, Marian C. Hawkey, Sandra Lauck

September 21, 2018

Presentation TCT 2018

Individualizing the Patient Care Pathway

Presenter: Sarah Clarke, Sandra Lauck

September 21, 2018

Presentation TCT 2018

Current Indications and Guidelines for TAVR

Presenter: Sarah Clarke, Kim Guibone

September 21, 2018

Presentation TCT 2018

Case Introduction: Aortic Stenosis

Presenter: Sarah Clarke, Kim Guibone, Marian C. Hawkey, Sandra Lauck

September 21, 2018

Presentation TCT 2018

First-In-Man Testing of a Dedicated Closure Device for Trans-Caval Access for Transcatheter Aortic Valve Replacement (Transmural Systems)

Presenter: Toby Rogers

September 21, 2018

Presentation TCT 2018

TCT-43: First-In-Human Experience of a Novel Transradial Device for Embolic Deflection During Transcatheter Aortic Valve Replacement

Presenter: David Hildick-Smith, Martin B. Leon, Andrejs Erglis

September 21, 2018

Presentation TCT 2018

TCT-43: First-In-Human Experience of a Novel Transradial Device for Embolic Deflection During Transcatheter Aortic Valve Replacement

Presenter: David Hildick-Smith, Martin B. Leon, Andrejs Erglis

September 21, 2018

Presentation TCT 2018

Endogenous Leaflet Restoration Technology (Xeltis) Status Update for Aortic Valve Replacement Therapy

Presenter: Christian M. Spaulding

September 21, 2018

Presentation TCT 2018

Bioprosthetic or Native Aortic Scallop Intentional Laceration to Prevent Iatrogenic Coronary Artery Obstruction During Transcatheter Aortic Valve Replacement: A Prospective IDE Trial (BASILICA)

Presenter: Jaffar M Khan

September 21, 2018

Presentation TCT 2018

TCT-15: Two-Year Outcomes After Transcatheter Aortic Valve Replacement With Mechanically- versus Self-Expandable Valves: Results From The REPRISE III Randomized Trial

Presenter: Charles J. Davidson, Jeffrey J. Popma, Michael J. Reardon

September 21, 2018

Presentation The Structural Heart Disease Summit 2018

Central Aortic Insufficiency Due to Transcatheter Heart Valve Defect After Transapical Transcatheter Aortic Valve Replacement

Presenter: A. Pieter Kappetein, Dee Dee Wang, Chad Morreale, MD

June 22, 2018

Advertisement

Point Volume Threshold Increases are Needed to Assess Quality and Improve Clinical Outcomes

Opinion Concerns of TAVR Access for Underserved Populations

Counterpoint Current and Future Demands Will Require TAVR Site Expansion

Point Access Considerations Can be Managed Without Significant TAVR Site Expansion

TCT-7: Predictors and Outcomes of Aborted Procedures During Elective Transcatheter Aortic Valve Replacement

TCT-4: Reduction of Stroke With Use of the Double-Filter Cerebral Embolic Protection Device in Patients Undergoing Transfemoral Aortic Valve Replacement With Self-Expandable, Mechanically Implantable And Balloon-Expandable Aortic Valves

TCT-98: Early Clinical Impact of Cerebral Embolic Protection With Transcatheter Aortic Valve Replacement, a Multicenter Study in the Netherlands

TCT-72: A Prospective Evaluation for Hypoattenuated Leaflet Thickening Following Transcatheter Aortic Valve Replacement

TCT-70: Incidence, Trends, and Risk Factors for Early Stroke after Transcatheter Aortic Valve Replacement in the First 5 years of US Clinical Practice: Report of the STS/ACC TVT Registry.

Case Conclusion

Individualizing the Patient Care Pathway

Current Indications and Guidelines for TAVR

Case Introduction: Aortic Stenosis

First-In-Man Testing of a Dedicated Closure Device for Trans-Caval Access for Transcatheter Aortic Valve Replacement (Transmural Systems)

TCT-43: First-In-Human Experience of a Novel Transradial Device for Embolic Deflection During Transcatheter Aortic Valve Replacement

TCT-43: First-In-Human Experience of a Novel Transradial Device for Embolic Deflection During Transcatheter Aortic Valve Replacement

Endogenous Leaflet Restoration Technology (Xeltis) Status Update for Aortic Valve Replacement Therapy

Bioprosthetic or Native Aortic Scallop Intentional Laceration to Prevent Iatrogenic Coronary Artery Obstruction During Transcatheter Aortic Valve Replacement: A Prospective IDE Trial (BASILICA)

TCT-15: Two-Year Outcomes After Transcatheter Aortic Valve Replacement With Mechanically- versus Self-Expandable Valves: Results From The REPRISE III Randomized Trial

Central Aortic Insufficiency Due to Transcatheter Heart Valve Defect After Transapical Transcatheter Aortic Valve Replacement

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content